ZLAB
Zai Lab Ltd
NASDAQ: ZLAB · HEALTHCARE · BIOTECHNOLOGY
$20.75
-6.28% today
Updated 2026-04-29
Market cap
$2.33B
P/E ratio
—
P/S ratio
5.07x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$16 – $44
Volume
0.8M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+4.8
Quality
C2.0
Profitability
F4.7
Valuation
C3/9
Piotroski F-Score
Weak
-0.8
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$35.34
+70.31%
12-Month target
—
—
Intrinsic (DCF)
$17.57
Margin of safety
-8.31%
2 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 17.00% QoQ
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -0.77 — distress zone
- Thin margins at -38.20%
- Negative free cash flow $-26.43M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $215.04M | $266.72M | $398.99M | $460.16M | $460.16M |
| Net income | $-443.29M | $-334.62M | $-257.10M | $-175.54M | $-50.41M |
| EPS | — | — | — | — | $-1.60 |
| Free cash flow | $-392.63M | $-206.67M | $-276.39M | $-158.89M | $-26.43M |
| Profit margin | -206.14% | -125.46% | -64.44% | -38.15% | -38.20% |
Peer comparison
Smart narrative
Zai Lab Ltd trades at $20.75. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -0.77, it sits in the distress. TTM revenue stands at $460.16M. with profit margins at -38.20%. Our DCF model estimates intrinsic value at $17.57.
Frequently asked questions
What is Zai Lab Ltd's stock price?
Zai Lab Ltd (ZLAB) trades at $20.75.
Is Zai Lab Ltd overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell). DCF value $17.57.
What is the price target of Zai Lab Ltd (ZLAB)?
The analyst target price is $35.34, representing +70.3% upside from the current price of $20.75.
What is the intrinsic value of Zai Lab Ltd (ZLAB)?
Based on our DCF model, intrinsic value is $17.57, a -8.3% margin of safety versus $20.75.
What is Zai Lab Ltd's revenue?
TTM revenue is $460.16M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-0.77 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryChina
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.07x
ROE-22.60%
Beta0.86
50D MA$20.15
200D MA$24.80
Shares out0.11B
Float0.96B
Short ratio—
Avg volume0.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—